Suven Life Sciences - Quaterly Results

07 May 2022 Evaluate
The total revenue hovered 171.10% to Rs. 42.21 millions for the March 2022 quarter as against Rs. 15.57 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -85.54 millions as compared to Net Loss of Rs. -85.09 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 further decreased to -73.54% as compared to -72.21% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 42.21 15.57 171.10 118.44 134.78 -12.12 118.44 134.78 -12.12
Other Income 1.18 13.23 -91.08 53.17 77.54 -31.43 53.17 77.54 -31.43
PBIDT -73.54 -72.21 1.84 -313.26 -227.93 37.44 -313.26 -227.93 37.44
Interest 0.98 1.76 -44.32 5.30 8.15 -34.97 5.30 8.15 -34.97
PBDT -74.52 -73.97 0.74 -318.56 -236.08 34.94 -318.56 -236.08 34.94
Depreciation 11.02 10.66 3.38 43.93 43.46 1.08 43.93 43.46 1.08
PBT -85.54 -84.63 1.08 -362.49 -279.54 29.67 -362.49 -279.54 29.67
TAX 0.00 0.46 0.00 0.00 -53.23 0.00 0.00 -53.23 0.00
Deferred Tax 0.00 0.46 0.00 0.00 -53.23 0.00 0.00 -53.23 0.00
PAT -85.54 -85.09 0.53 -362.49 -226.31 60.17 -362.49 -226.31 60.17
Equity 145.38 127.28 14.22 145.38 127.28 14.22 145.38 127.28 14.22
PBIDTM(%) -174.22 -463.78 -62.43 -264.49 -169.11 56.40 -264.49 -169.11 56.40

Suven Life Sciences Share Price

130.00 -3.50 (-2.62%)
27-Jan-2026 11:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.70
Dr. Reddys Lab 1243.20
Cipla 1308.00
Zydus Lifesciences 892.60
Lupin 2151.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×